| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Y-C Tse-Dinh | |
| P433 | issue | 1 | |
| P921 | main subject | infectious disease | Q18123741 |
| P304 | page(s) | 3-9 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Infectious disorders drug targets | Q27020376 |
| P1476 | title | Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases | |
| P478 | volume | 7 |
| Q27681978 | A New Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8 Bound to DNA Gyrase Gives Fresh Insight into the Mechanism of Inhibition |
| Q36421838 | A highly conserved protein of unknown function is required by Sinorhizobium meliloti for symbiosis and environmental stress protection. |
| Q34759634 | A rapid procedure to purify Escherichia coli DNA topoisomerase I |
| Q36337701 | An endogenous protein inhibitor, YjhX (TopAI), for topoisomerase I from Escherichia coli. |
| Q37242375 | Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol |
| Q28486816 | Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI |
| Q41441209 | Asp-to-Asn substitution at the first position of the DxD TOPRIM motif of recombinant bacterial topoisomerase I is extremely lethal to E. coli |
| Q37998090 | Bacterial DNA replication enzymes as targets for antibacterial drug discovery |
| Q28486558 | Characterization of an interplay between a Mycobacterium tuberculosis MazF homolog, Rv1495 and its sole DNA topoisomerase I |
| Q36328210 | Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria |
| Q42004601 | DNA G-segment bending is not the sole determinant of topology simplification by type II DNA topoisomerases. |
| Q37383911 | Effects of magnesium and related divalent metal ions in topoisomerase structure and function. |
| Q34095957 | Evaluating the genotoxicity of topoisomerase-targeted antibiotics |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q50003254 | Facile synthesis of tetrahydroprotoberberine and protoberberine alkaloids from protopines and study on their antibacterial activities |
| Q34821381 | Identification of the likely translational start of Mycobacterium tuberculosis GyrB. |
| Q37694351 | In front of and behind the replication fork: bacterial type IIA topoisomerases. |
| Q54358881 | Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. |
| Q36824017 | Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region |
| Q41878053 | Inhibitory effect of N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide on Haemophilus spp. planktonic or biofilm-forming cells. |
| Q36364221 | Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA. |
| Q36457138 | Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I. |
| Q37774376 | New quinolone antibiotics: a survey of the literature from 2005 to 2010. |
| Q47108181 | Physiological Roles of DNA Double-Strand Breaks |
| Q37792983 | Possible structural and functional determinants contributing to the clastogenicity of pharmaceuticals |
| Q36305708 | Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage |
| Q35216986 | Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles |
| Q46864203 | Structure-activity relationship studies of microbiologically active thiosemicarbazides derived from hydroxybenzoic acid hydrazides |
| Q35074386 | Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors |
| Q33351069 | The ancestral role of ATP hydrolysis in type II topoisomerases: prevention of DNA double-strand breaks |
| Q42408670 | The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase. |
| Q43175095 | Topo2008: DNA topoisomerases in biology and medicine |
| Q35037379 | Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex |
| Q28538627 | Toward discovering new anti-cancer agents targeting topoisomerase IIα: a facile screening strategy adaptable to high throughput platform |
| Q47181942 | Type IA DNA Topoisomerases: A Universal Core and Multiple Activities. |
Search more.